Ellen Lubman - Jan 6, 2022 Form 4 Insider Report for Werewolf Therapeutics, Inc. (HOWL)

Role
Chief Business Officer
Signature
/s/ Reid Leonard, Attorney-in-fact
Stock symbol
HOWL
Transactions as of
Jan 6, 2022
Transactions value $
$0
Form type
4
Date filed
1/18/2022, 05:30 PM
Next filing
Jan 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOWL Stock Option (right to buy) Award $0 +51.1K $0.00 51.1K Jan 6, 2022 Common Stock 51.1K $11.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on January 6, 2022 with a Vesting Commencement Date of January 1, 2022. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the Vesting Commencement Date and 2.0833% of the shares vesting each month thereafter through January 1, 2026.